Kurz gefasst
Fachartikel in der Zeitschrift Science, 2023. Verfasst von Marta Filizola und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Hauptthemen laut MEDLINE: Drug Discovery, Receptors, Adrenergic, beta-1, Adrenergic beta-1 Receptor Agonists. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 11 Literaturangaben. Gefördert von: NIDA NIH HHS, NIMH NIH HHS, NIH HHS.
Abstract (Originalsprache)
Advancing drug discovery requires increasingly integrative structural biology approaches
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
- Department of Molecular Pharmacology and Therapeutics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
- Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.
Förderung
- NIDA NIH HHS
- NIMH NIH HHS
- NIH HHS
Zitieren
APA
Filizola, M., & Javitch, J. A. (2023). Deciphering downstream receptor signaling. Science. https://doi.org/10.1126/science.adm8393
Vancouver
Filizola M, Javitch JA. Deciphering downstream receptor signaling. Science. 2023. doi:10.1126/science.adm8393
BibTeX
@article{Filizola2023,
author = {Filizola, Marta and Javitch, Jonathan A},
title = {Deciphering downstream receptor signaling},
journal = {Science},
year = {2023},
doi = {10.1126/science.adm8393}
}
EUVIMED